Drimva

HeartFlow

Territory Account Manager - Fresno, CA

$125K–$200K

Fresno, CA +1 · Manager · Full-time · Posted Sep 15, 2026

Location
Fresno, CA
Home based, United States
Experience
4-year degree with 5+ years of related sales or clinical experience, or 2-year degree with 7+ years of related sales or clinical experience.
Education
4-year degree or 2-year degree, according to the stated experience alternative.

About the job

Drive adoption and growth of HeartFlow’s cardiovascular diagnostic technology across a designated territory by developing customer relationships, educating clinicians, and supporting account programs.

What you'll do

  • Develop and execute business development plans with strategic accounts, coordinating HeartFlow teams and resources to support clinical pathway adoption.
  • Build relationships with physicians and other clinical stakeholders; educate them on HeartFlow’s value proposition through presentations and discussions.
  • Grow usage and referrals in assigned accounts, with performance measured against quota, cCTA growth, and FFRct penetration and case growth.

What they ask for

  • Proven sales skills and a track record of sales achievement.
  • 4-year degree with 5+ years of related sales or clinical experience, or 2-year degree with 7+ years of related sales or clinical experience.
  • Ability to learn and explain clinical and technical information to healthcare professionals.
  • Excellent verbal and written communication skills.

Nice to have

  • Knowledge of cardiac patient pathways and diagnostic technology; experience building and supporting clinical programs.
  • Degree in Science, Medical, Business, Marketing, or a Technical field; experience in relevant medical or cardiovascular settings is highly desired.

Pay

$125,000 USD base compensation; $200,000 USD total target compensation (base plus variable/commission)

Tools

Salesforce.com, Heartflow FFR CT Analysis, RoadMap™Analysis, Plaque Analysis, cCTA, FFRct

AI focus

Promote adoption of HeartFlow’s AI-driven, non-invasive cardiovascular diagnostic technology; no AI development work is stated.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)